Liberty Biopharma Inc (CVE:LTY – Get Free Report)’s stock price crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of C$2.00 and traded as low as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares trading hands.
Liberty Biopharma Stock Performance
The firm’s 50 day moving average is C$2.00 and its 200-day moving average is C$2.00. The stock has a market capitalization of C$21.54 million and a price-to-earnings ratio of -12.66. The company has a debt-to-equity ratio of 8.19, a quick ratio of 0.12 and a current ratio of 0.12.
Liberty Biopharma Company Profile
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
Featured Stories
- Five stocks we like better than Liberty Biopharma
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- Conference Calls and Individual Investors
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
